Awards Support Innovative Prostate Cancer Research
The Robert H. Lurie Comprehensive Cancer Center’s SPORE in Prostate Cancer and Polsky Urologic Cancer Institute announce the following awards in support of innovative prostate cancer research:
SPORE Supported Awards
Targeting Asparagine-dependency in TP53-mutant Prostate Cancer Principal Investigator: Sarki Abdulkadir, MD, PhD |
|
AI-Powered Hybrid Multidimensional MRI (HM-MRI) to Principal Investigator: Ulas Bagci, PhD |
|
A Classifier Integrating Digital Histologic Biomarkers and Clinical Features for Enhanced Active Surveillance Risk Stratification in Prostate Cancer Principal Investigators: Ashley Ross, MD, PhD Lee Cooper, PhD |
|
|
Prostate cancer cell-mediated reprogramming of the tumor microenvironment in metastasis Principal Investigator: Mindy Graham, PhD |
Development of a B-Cell Therapy (BVax) for Prostate Cancer Principal Investigator: Catalina Lee-Chang, PhD |
|
Molecular Mechanisms of Ligand-Independent Transcriptional Activation by Androgen Receptor Principal Investigator: Ishwar Radhakrishnan, PhD |
|
Targeting ENPP1-STING pathway to enhance PARP inhibitor in prostate cancer Principal Investigator: Akash Patnaik, MD, PhD |
|
CD73 blockade therapy sensitizing PARP inhibition in advanced prostate cancer Principal Investigator: Bin Zhang, MD, PhD |
|
Three-In-One Radiosensitizer for Cancer Therapy Principal Investigator: C. Shad Thaxton, MD, PhD |
|
BAT and Docetaxel to Prime Sensitivity to Cytotoxic Therapy Principal Investigator: David VanderWeele, MD, PhD
|